| Act as knowledge concentrated industry of high technique, high risk, high devotion and high repayment, pharmaceutical industry has the good reputation which never decline. In recent years, along with the fierce development of global economic integration, the multinational medicine companies accelerate to transfer the raw material medicine business of lower profit to the developing countries in succession. The variety of the exterior environment brought the opportunity to development of the China-made medicine business enterprise. However, the quantity of patent medicine, the creative ability and R&D level are to measure the competition ability of the medicine business. Because of these ability could bring the monopolization profits. At present, compared with big medicine business, our medicine enterprises choose only produce non-patent medicine and the raw material medicine. Therefore, it is very often that many medicine enterprises sometimes even more than one hundred produce the same species. At the same time, lack of the difference on the management strategy, the aspects of quality, function and brand and so on, make the same kind drugs in the meantime. Therefore, "price war" becomes the only choices for many medicine enterprises. Such as addition frost on snow, this action damaged heavily the competition ability of China-made medicine business enterprise which profit is not high originally. Therefore, it is important that carry out difference strategy which can crack "price war", discover the Core Competence of the Corporation, make the business enterprise successful.Based on the review of enterprise competed position and difference strategic, this paper analysis the dynamic reason of the China-made medicine business enterprise' difference strategic, set up the difference strategic model and give analysis of case which is made of different position' medicine enterprise, put forward to the necessary measure to promote our county' enterprise in the end. |
